These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17697064)

  • 1. Discordance between intramuscular triglyceride and insulin sensitivity in skeletal muscle of Zucker diabetic rats after treatment with fenofibrate and rosiglitazone.
    Nadeau KJ; Ehlers LB; Aguirre LE; Reusch JE; Draznin B
    Diabetes Obes Metab; 2007 Sep; 9(5):714-23. PubMed ID: 17697064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic hepatic steatosis in Zucker diabetic rats: spontaneous evolution and effects of metformin and fenofibrate.
    Forcheron F; Abdallah P; Basset A; del Carmine P; Haffar G; Beylot M
    Obesity (Silver Spring); 2009 Jul; 17(7):1381-9. PubMed ID: 19553925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise training and calorie restriction increase SREBP-1 expression and intramuscular triglyceride in skeletal muscle.
    Nadeau KJ; Ehlers LB; Aguirre LE; Moore RL; Jew KN; Ortmeyer HK; Hansen BC; Reusch JE; Draznin B
    Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E90-8. PubMed ID: 16449296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiponectin receptors: expression in Zucker diabetic rats and effects of fenofibrate and metformin.
    Metais C; Forcheron F; Abdallah P; Basset A; Del Carmine P; Bricca G; Beylot M
    Metabolism; 2008 Jul; 57(7):946-53. PubMed ID: 18555836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
    Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
    Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fenofibrate prevents Rosiglitazone-induced body weight gain in ob/ob mice.
    Carmona MC; Louche K; Nibbelink M; Prunet B; Bross A; Desbazeille M; Dacquet C; Renard P; Casteilla L; Pénicaud L
    Int J Obes (Lond); 2005 Jul; 29(7):864-71. PubMed ID: 15917863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cevoglitazar, a dual PPARalpha/gamma agonist, on ectopic fat deposition in fatty Zucker rats.
    Laurent D; Gounarides JS; Gao J; Boettcher BR
    Diabetes Obes Metab; 2009 Jun; 11(6):632-6. PubMed ID: 19175377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of glucose tolerance in Zucker diabetic fatty rats by long-term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone.
    Wargent E; Stocker C; Augstein P; Heinke P; Meyer A; Hoffmann T; Subramanian A; Sennitt MV; Demuth HU; Arch JR; Cawthorne MA
    Diabetes Obes Metab; 2005 Mar; 7(2):170-81. PubMed ID: 15715890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of fenofibrate on gene expression of carnitine palmitoyltransferase 1 in liver and skeletal muscle and its influence on insulin sensitivity].
    Bai XP; Li HL; Yang WY; Xiao JZ; Wang B; Du RQ; Lou DJ
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):268-70. PubMed ID: 18361841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left-ventricular diastolic dysfunction may be prevented by chronic treatment with PPAR-alpha or -gamma agonists in a type 2 diabetic animal model.
    Kim SK; Zhao ZS; Lee YJ; Lee KE; Kang SM; Choi D; Lim SK; Chung N; Lee HC; Cha BS
    Diabetes Metab Res Rev; 2003; 19(6):487-93. PubMed ID: 14648808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats.
    Choi KC; Ryu OH; Lee KW; Kim HY; Seo JA; Kim SG; Kim NH; Choi DS; Baik SH; Choi KM
    Biochem Biophys Res Commun; 2005 Oct; 336(3):747-53. PubMed ID: 16157299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combination of CLA-DAG oil modifies the diabetic phenotype in male Zucker diabetic fatty rats.
    Iqbal MJ; Higginbotham A; Chickris N; Bollaert M; Rockway S; Banz WJ
    Horm Metab Res; 2008 Apr; 40(4):262-8. PubMed ID: 18548385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidiabetic and hypolipidemic potential of DRF 2519--a dual activator of PPAR-alpha and PPAR-gamma.
    Chakrabarti R; Misra P; Vikramadithyan RK; Premkumar M; Hiriyan J; Datla SR; Damarla RK; Suresh J; Rajagopalan R
    Eur J Pharmacol; 2004 May; 491(2-3):195-206. PubMed ID: 15140637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postexercise muscle triacylglycerol and glycogen metabolism in obese insulin-resistant zucker rats.
    Bruce CR; Lee JS; Kiens B; Hawley JA
    Obes Res; 2004 Jul; 12(7):1158-65. PubMed ID: 15292481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes.
    Seo YS; Kim JH; Jo NY; Choi KM; Baik SH; Park JJ; Kim JS; Byun KS; Bak YT; Lee CH; Kim A; Yeon JE
    J Gastroenterol Hepatol; 2008 Jan; 23(1):102-9. PubMed ID: 18171348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered triglyceride-rich lipoprotein production in Zucker diabetic fatty rats.
    Chirieac DV; Collins HL; Cianci J; Sparks JD; Sparks CE
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E42-9. PubMed ID: 14970003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pan-PPAR agonist beneficial effects in overweight mice fed a high-fat high-sucrose diet.
    Fernandes-Santos C; Carneiro RE; de Souza Mendonca L; Aguila MB; Mandarim-de-Lacerda CA
    Nutrition; 2009; 25(7-8):818-27. PubMed ID: 19268533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor subtype-specific regulation of hepatic and peripheral gene expression in the Zucker diabetic fatty rat.
    Dana SL; Hoener PA; Bilakovics JM; Crombie DL; Ogilvie KM; Kauffman RF; Mukherjee R; Paterniti JR
    Metabolism; 2001 Aug; 50(8):963-71. PubMed ID: 11474486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNF-alpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c).
    Endo M; Masaki T; Seike M; Yoshimatsu H
    Exp Biol Med (Maywood); 2007 May; 232(5):614-21. PubMed ID: 17463157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPAR-alpha agonist fenofibrate induces renal CYP enzymes and reduces blood pressure and glomerular hypertrophy in Zucker diabetic fatty rats.
    Zhao X; Li LY
    Am J Nephrol; 2008; 28(4):598-606. PubMed ID: 18277067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.